Wednesday, April 15, 2026

Imeroprubart vs. Batoclimab: Which Treatment Will Revolutionize Graves’ Disease Management?

HanAll Biopharma's Imeroprubart targets Graves' disease, showing promise with IgG suppression and user-friendly auto-injector delivery.

INFINITE Announces Full-Group Return with ‘LIKE INFINITE’ and 15th Anniversary Celebration

INFINITE announces a full-group comeback on March 6, celebrating 15 years since debut with a new mini-album, LIKE INFINITE.

Trump’s Tariff Barrage & Fed Pressure Trigger an Exodus of Funds, Brains from US

Trump's policies are driving global funds and skilled professionals away from the U.S., leading to a significant brain drain.

Tag: U.S. blockade

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.